binx health Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-waived, FDA-cleared binx io

February 14, 2024

binx health, a healthcare technology and diagnostics company focused on expanding Sexually Transmitted Infection testing at the Point-of-Care, announced a national distribution agreement with Cardinal Health to expand access to care with the CLIA-waived, FDA-cleared binx io to improve the timely diagnosis of chlamydia (CT) and gonorrhea (NG).


Read more